Kaanders JH - Search Results

1

ARCON: a novel biology-based approach in radiotherapy.

Kaanders JH, Bussink J, van der Kogel AJ. Kaanders JH, et al. Lancet Oncol. 2002 Dec;3(12):728-37. doi: 10.1016/s1470-2045(02)00929-4. Lancet Oncol. 2002. PMID: 12473514 Review.

2

ARCON: accelerated radiotherapy with carbogen and nicotinamide in non small cell lung cancer: a phase I/II study by the EORTC.

Bernier J, Denekamp J, Rojas A, Trovò M, Horiot JC, Hamers H, Antognoni P, Dahl O, Richaud P, Kaanders J, van Glabbeke M, Piérart M. Bernier J, et al. Radiother Oncol. 1999 Aug;52(2):149-56. doi: 10.1016/s0167-8140(99)00106-1. Radiother Oncol. 1999. PMID: 10577700 Clinical Trial.

3

ARCON: experience in 215 patients with advanced head-and-neck cancer.

Kaanders JH, Pop LA, Marres HA, Bruaset I, van den Hoogen FJ, Merkx MA, van der Kogel AJ. Kaanders JH, et al. Int J Radiat Oncol Biol Phys. 2002 Mar 1;52(3):769-78. doi: 10.1016/s0360-3016(01)02678-5. Int J Radiat Oncol Biol Phys. 2002. PMID: 11849800 Clinical Trial.

4

Effects of breathing a hyperoxic hypercapnic gas mixture on blood oxygenation and vascularity of head-and-neck tumors as measured by magnetic resonance imaging.

Rijpkema M, Kaanders JH, Joosten FB, van der Kogel AJ, Heerschap A. Rijpkema M, et al. Among authors: kaanders jh. Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1185-91. doi: 10.1016/s0360-3016(02)02825-0. Int J Radiat Oncol Biol Phys. 2002. PMID: 12128119

5

Arterial baroreflex and peripheral chemoreflex function after radiotherapy for laryngeal or pharyngeal cancer.

Timmers HJ, Karemaker JM, Wieling W, Kaanders JH, Folgering HT, Marres HA, Lenders JW. Timmers HJ, et al. Among authors: kaanders jh. Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1203-10. doi: 10.1016/s0360-3016(02)02827-4. Int J Radiat Oncol Biol Phys. 2002. PMID: 12128121

6

Pharmacology and toxicity of nicotinamide combined with domperidone during fractionated radiotherapy.

Bussink J, Stratford MR, van der Kogel AJ, Folkes LK, Kaanders JH. Bussink J, et al. Among authors: kaanders jh. Radiother Oncol. 2002 Jun;63(3):285-91. doi: 10.1016/s0167-8140(02)00072-5. Radiother Oncol. 2002. PMID: 12142092

7

Vascular architecture, hypoxia, and proliferation in first-generation xenografts of human head-and-neck squamous cell carcinomas.

Ljungkvist AS, Bussink J, Rijken PF, Kaanders JH, van der Kogel AJ, Denekamp J. Ljungkvist AS, et al. Among authors: kaanders jh. Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):215-28. doi: 10.1016/s0360-3016(02)02938-3. Int J Radiat Oncol Biol Phys. 2002. PMID: 12182995

8

Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer.

Kaanders JH, Wijffels KI, Marres HA, Ljungkvist AS, Pop LA, van den Hoogen FJ, de Wilde PC, Bussink J, Raleigh JA, van der Kogel AJ. Kaanders JH, et al. Cancer Res. 2002 Dec 1;62(23):7066-74. Cancer Res. 2002. PMID: 12460928 Clinical Trial.

9

Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers.

Bussink J, Kaanders JH, van der Kogel AJ. Bussink J, et al. Among authors: kaanders jh. Radiother Oncol. 2003 Apr;67(1):3-15. doi: 10.1016/s0167-8140(03)00011-2. Radiother Oncol. 2003. PMID: 12758235 Review.

10

Set-up improvement in head and neck radiotherapy using a 3D off-line EPID-based correction protocol and a customised head and neck support.

van Lin EN, van der Vight L, Huizenga H, Kaanders JH, Visser AG. van Lin EN, et al. Among authors: kaanders jh. Radiother Oncol. 2003 Aug;68(2):137-48. doi: 10.1016/s0167-8140(03)00134-8. Radiother Oncol. 2003. PMID: 12972308

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results